FDA Gives Approval to Market OTC Version of Prevacid

The FDA has given its approval for Novartis to market Prevacid 24HR (lansoprazole delayed-release capsules 15 mg) as the over-the-counter (OTC) version of the Proton Pump Inhibitor (PPI) Prevacid. This is the first over-the-counter PPI for the treatment of frequent heartburn since 2003. Prevacid 24HR is expected to be available sometime in 2009.

Prevacid 24HR will be in its original prescription formulation, with a once-daily dosage. The FDA approved Prevacid 24HR in the form of 15mg delayed-release capsules. Course of treatment would be taking Prevacid 24HR once per day before eating in the morning to treat frequent heartburn. Although some people experienced complete relief of symptoms within 24 hours, it may take one to four days for full effect.

For more information about Prevacid 24HR, and to be informed of any updates in information, you can visit http://www.Prevacid24HR.com